Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial
Lauren C. Tindale, Jason S. Richardson, Deborah M. Anderson, Jason Mendy, Sufia Muhammad, Tobi Loreth, Sarah Royalty Tredo, Roshan Ramanathan, Victoria A. Jenkins, Lisa Bedell, Patrick Ajiboye
Topics & Concepts
ImmunogenicityMedicinePlaceboVirusChikungunyaVirologyDouble blindRandomized controlled trialVirus-like particleChikungunya feverImmunologyInternal medicineAlternative medicineAntibodyBiologyRecombinant DNAPathologyBiochemistryGeneMosquito-borne diseases and controlBiological Research and Disease StudiesViral Infections and Outbreaks Research